Ironwood Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
796.78 | 63.23 | 1160.15% | 168.42 | +373.08% |
| P/S |
|
2 | 32.67 | -93.89% |
|
|
| P/BV |
|
-2.33 | 18.83 | -112.36% |
|
|
| P/FCF |
|
14.99 | -11.83 | -226.69% |
|
|
| Ev/Ebitda |
|
12.09 | 274.42 | -95.59% |
|
|
| Ev/S |
|
3.45 | 21.54 | -83.99% |
|
|
| Ev/FCF |
|
11.72 | -15.84 | -174.01% |
|
|
| E/P |
|
0.000568 | 0.0188 | -96.99% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
28.53 | -10.92 | -361.2% | -6.37 | -547.49% |
| ROE |
|
-0.2718 | 14.17 | -101.92% |
|
|
| ROA |
|
0.2141 | 1.18 | -81.88% |
|
|
| ROIC |
|
66.79 | 7.63 | 774.86% |
|
|
| ROS |
|
0.2504 | -22.82 | -101.1% |
|
|
| ROCE |
|
-32.6 | 6.29 | -618.37% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.98 | 1.27 | 370.43% | 2.96 | +101.76% |
| Nеt Debt/Ebitda |
|
5.1 | -10.2 | -149.95% |
|
|
| Debt/Ratio |
|
1.71 | 0.1978 | 763.75% |
|
|
| Debt/Equity |
|
-2.16 | 1.3 | -265.87% |
|
|
| Debt/Net Income |
|
681.23 | 2.46 | 27549.84% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5277 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.9474 | -100% | ||
| DSI |
|
0 | 0.2279 | -100% |
|
|
| Average dividend growth |
|
0 | 1.14 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.554 | -100% |
|
|
| Average percentage for payments |
|
63.5 | 64.78 | -1.98% |
|
|
| Difference from average difference in sector |
|
-0.5277 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-9.78 | 68.41 | -114.3% | ||
| Growth impulse Ebitda in 5 years |
|
-37.31 | 33.15 | -212.55% | ||
| Growth impulse Net Income in 5 years |
|
-99.17 | -6.56 | 1411.74% | ||
| Growth impulse FCF in 5 years |
|
-38.08 | 27.51 | -238.42% | ||
| Growth impulse EPS in 5 years |
|
-99.17 | 24.03 | -512.69% |
IP Score
2.91/10
